Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 7 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
GYNECOLOGY SOCIETY DEVELOPMENT from Waimes, company number BE0807537767, closed financial year 2025 with a result of € 3,111 after tax. For that financial year GYNECOLOGY SOCIETY DEVELOPMENT recorded a gross margin of € 34,411 and equity of € -37,543. Compared with financial year 2024, the result moved from € 18,149 to € 3,111. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ -37,543
▲ € 3,111 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,111
▼ 83% vs 2024
Profit after tax over the fiscal year.
€ 3,595
▼ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -49,943.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 18,961
▼ 15% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 29,127
▲ € 23,912 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 30,867
▲ 195% vs 2024
€ 6,634 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 7,217
▲ 13% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 410
▼ 82% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 78,097 | € 58,290 | € 45,419 | € 34,411 | ▼ 24% |
| Profit after taxes | € 13,727 | € -58,469 | € 18,149 | € 3,111 | ▼ 83% |
| Equity | € -334 | € -58,804 | € -40,654 | € -37,543 | ▲ € 3,111 |
| Total debts | € 255,727 | € 65,455 | € 53,618 | € 78,832 | ▲ 47% |
| Cash | € 8,441 | € 3,220 | € 3,716 | € 3,595 | ▼ 3% |
| Land & buildings | € 168,945 | - | - | - | |
| Retained profit | € -12,734 | € -71,204 | € -53,054 | € -49,943 | ▲ € 3,111 |
| Bank debt | € 245,855 | € 12,948 | € 10,458 | € 30,867 | ▲ 195% |
| Balance sheet total | € 255,393 | € 6,651 | € 12,964 | € 41,288 | ▲ 218% |
Key figures of GYNECOLOGY SOCIETY DEVELOPMENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 May 2027.
What happened to GYNECOLOGY SOCIETY DEVELOPMENT?
What happened at GYNECOLOGY SOCIETY DEVELOPMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3,111 (▼ 83% vs 2024). filed late Source: NBB ↗
- New establishment in Waimes. KBO
- Radu Pandeli became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 13,727 profit in 2022 to € 3,111 profit in 2025.
Paid € 25,822 in corporate taxes since 2022.
Best year ever: 2024, with € 18,149 profit.
A new publication or filing at GYNECOLOGY SOCIETY DEVELOPMENT? We notify you, reason included.
Follow GYNECOLOGY SOCIETY DEVELOPMENTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind GYNECOLOGY SOCIETY DEVELOPMENT is Radu Pandeli.
Directors
According to the 2025 annual accounts
Radu Pandeli
Director
since 2008
Establishments
Establishment units
Physical locations of this company
Rue de Hottleux 112/1
4950 Waimes
Rue de Hottleux 112 box 1
4950 Waimes
Active since 25 November 2011
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0807.537.767
- VAT number
- BE 0807.537.767
- Registered office
- Rue de Hottleux 112/1, 4950 Waimes
- Names & denominations
- GYNECOLOGY SOCIETY DEVELOPMENT · G.S.D.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 November 2008
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten